BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

695 related articles for article (PubMed ID: 16386635)

  • 1. Comparison of cytomegalovirus viral load measure by real-time PCR with pp65 antigenemia for the diagnosis of cytomegalovirus disease in solid organ transplant patients.
    Hernando S; Folgueira L; Lumbreras C; San Juan R; Maldonado S; Prieto C; Babiano MJ; Delgado J; Andres A; Moreno E; Aguado JM; Otero JR
    Transplant Proc; 2005 Nov; 37(9):4094-6. PubMed ID: 16386635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of CMV load in solid organ transplant recipients by pp65 antigenemia and real-time quantitative DNA PCR assay: correlation with pp67 RNA detection.
    Mengoli C; Cusinato R; Biasolo MA; Cesaro S; Parolin C; Palù G
    J Med Virol; 2004 Sep; 74(1):78-84. PubMed ID: 15258972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of cytomegalovirus load assessed by real-time PCR to pp65 antigenemia in organ transplant recipients.
    Sanghavi SK; Abu-Elmagd K; Keightley MC; St George K; Lewandowski K; Boes SS; Bullotta A; Dare R; Lassak M; Husain S; Kwak EJ; Paterson DL; Rinaldo CR
    J Clin Virol; 2008 Aug; 42(4):335-42. PubMed ID: 18495527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitation of cytomegalovirus DNA by real-time polymerase chain reaction in peripheral blood specimens of patients with solid organ transplants: comparison with end-point PCR and pp65 antigen test.
    Allice T; Enrietto M; Pittaluga F; Varetto S; Franchello A; Marchiaro G; Ghisetti V
    J Med Virol; 2006 Jul; 78(7):915-22. PubMed ID: 16721848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole blood real-time quantitative PCR for cytomegalovirus infection follow-up in transplant recipients.
    Garrigue I; Boucher S; Couzi L; Caumont A; Dromer C; Neau-Cransac M; Tabrizi R; Schrive MH; Fleury H; Lafon ME
    J Clin Virol; 2006 May; 36(1):72-5. PubMed ID: 16481215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective study comparing cytomegalovirus antigenemia, DNAemia and RNAemia tests in guiding pre-emptive therapy in thoracic organ transplant recipients.
    Lehto JT; Lemström K; Halme M; Lappalainen M; Lommi J; Sipponen J; Harjula A; Tukiainen P; Koskinen PK
    Transpl Int; 2005 Dec; 18(12):1318-27. PubMed ID: 16297050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of a quantitative PCR assay for CMV infection in liver transplant recipients: an intent to find the optimal cut-off value.
    Martín-Dávila P; Fortún J; Gutiérrez C; Martí-Belda P; Candelas A; Honrubia A; Barcena R; Martínez A; Puente A; de Vicente E; Moreno S
    J Clin Virol; 2005 Jun; 33(2):138-44. PubMed ID: 15911429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of quantitative competitive polymerase chain reaction-enzyme-linked immunosorbent assay with LightCycler-based polymerase chain reaction for measuring cytomegalovirus DNA in patients after hematopoietic stem cell transplantation.
    Pumannova M; Roubalova K; Vitek A; Sajdova J
    Diagn Microbiol Infect Dis; 2006 Feb; 54(2):115-20. PubMed ID: 16406183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitation of human cytomegalovirus in recipients of solid organ transplants by real-time quantitative PCR and pp65 antigenemia.
    Mengelle C; Pasquier C; Rostaing L; Sandres-Sauné K; Puel J; Berges L; Righi L; Bouquies C; Izopet J
    J Med Virol; 2003 Feb; 69(2):225-31. PubMed ID: 12683412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosing cytomegalovirus disease in CMV seropositive renal allograft recipients: a comparison between the detection of CMV DNAemia by polymerase chain reaction and antigenemia by CMV pp65 assay.
    Lo CY; Ho KN; Yuen KY; Lui SL; Li FK; Chan TM; Lo WK; Cheng IK
    Clin Transplant; 1997 Aug; 11(4):286-93. PubMed ID: 9267717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of cytomegalovirus (CMV) viremia using the pp65 antigenemia assay, the amplicor CMV test, and a semi-quantitative polymerase chain reaction test after allogeneic marrow transplantation.
    Ksouri H; Eljed H; Greco A; Lakhal A; Torjman L; Abdelkefi A; Ben Othmen T; Ladeb S; Slim A; Zouari B; Abdeladhim A; Ben Hassen A
    Transpl Infect Dis; 2007 Mar; 9(1):16-21. PubMed ID: 17313466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring of CMV infection: a comparison of PCR from whole blood, plasma-PCR, pp65-antigenemia and virus culture in patients after bone marrow transplantation.
    Hebart H; Müller C; Löffler J; Jahn G; Einsele H
    Bone Marrow Transplant; 1996 May; 17(5):861-8. PubMed ID: 8733710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinically-based determination of safe DNAemia cutoff levels for preemptive therapy or human cytomegalovirus infections in solid organ and hematopoietic stem cell transplant recipients.
    Lilleri D; Baldanti F; Gatti M; Rovida F; Dossena L; De Grazia S; Torsellini M; Gerna G
    J Med Virol; 2004 Jul; 73(3):412-8. PubMed ID: 15170637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicentric evaluation of a new commercial cytomegalovirus real-time PCR quantitation assay.
    Gouarin S; Vabret A; Scieux C; Agbalika F; Cherot J; Mengelle C; Deback C; Petitjean J; Dina J; Freymuth F
    J Virol Methods; 2007 Dec; 146(1-2):147-54. PubMed ID: 17673304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring low cytomegalovirus viremia in transplanted patients by a real-time PCR on plasma.
    Schvoerer E; Henriot S; Zachary P; Freitag R; Fuchs A; Fritsch S; Risch S; Meyer N; Caillard S; Lioure B; Stoll-Keller F
    J Med Virol; 2005 May; 76(1):76-81. PubMed ID: 15778970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of real-time PCR and pp65 antigen assays for monitoring the development of Cytomegalovirus disease in recipients of solid organ and bone marrow transplants.
    Marchetti S; Santangelo R; Manzara S; D'onghia S; Fadda G; Cattani P
    New Microbiol; 2011 Apr; 34(2):157-64. PubMed ID: 21617827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of two quantitative CMV PCR tests, Cobas Amplicor CMV Monitor and TaqMan assay, and pp65-antigenemia assay in the determination of viral loads from peripheral blood of organ transplant patients.
    Piiparinen H; Höckerstedt K; Grönhagen-Riska C; Lautenschlager I
    J Clin Virol; 2004 Jul; 30(3):258-66. PubMed ID: 15135746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Investigation of cytomegalovirus positivity in the peripheral blood samples of risky patients by shell-vial cell culture, antigenemia test and real-time polymerase chain reaction].
    Gökahmetoğlu S; Yağmur G; Mutlu Sarıgüzel F; Deniz E
    Mikrobiyol Bul; 2011 Apr; 45(2):288-95. PubMed ID: 21644072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative analysis of HCMV DNA load in whole blood of renal transplant patients using real-time PCR assay.
    Gouarin S; Vabret A; Gault E; Petitjean J; Regeasse A; Hurault de Ligny B; Freymuth F
    J Clin Virol; 2004 Mar; 29(3):194-201. PubMed ID: 14962789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-time PCR assay compared with antigenemia assay for detecting cytomegalovirus infection in kidney transplant recipients.
    Kim DJ; Kim SJ; Park J; Choi GS; Lee S; Kwon CD; Ki C; Joh J
    Transplant Proc; 2007 Jun; 39(5):1458-60. PubMed ID: 17580161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.